Genenta Science SpA ADR (NASDAQ:GNTA) — Stock Price
Genenta Science SpA ADR (NASDAQ:GNTA) is currently trading at $0.70 USD, down 1.69% today. Over the past 52 weeks, shares have ranged between $0.63 and $6.20. This page tracks Genenta Science SpA ADR's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Genenta Science SpA ADR.
Genenta Science SpA ADR (GNTA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Genenta Science SpA ADR's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Genenta Science SpA ADR Income Statement — Revenue, Profit & Earnings by Year
Genenta Science SpA ADR's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $26.97K | $46.51K | $41.70K | $6.00K | $5.10K |
| Gross Profit | $-26.97K | $-46.51K | $-41.70K | $-6.00K | $-5.10K |
| Research & Development | $2.59 Million | $5.03 Million | $6.36 Million | $5.21 Million | $3.53 Million |
| SG&A | $3.90 Million | $4.95 Million | $5.26 Million | $5.71 Million | $2.30 Million |
| Total Operating Expenses | $6.32 Million | $10.15 Million | $11.48 Million | $10.78 Million | $5.92 Million |
| Operating Income | $-6.34 Million | $-10.20 Million | $-11.53 Million | $-10.79 Million | $-5.93 Million |
| EBITDA | $-6.32 Million | $-10.15 Million | $-11.48 Million | $-10.78 Million | $-5.92 Million |
| EBIT | $-6.34 Million | $-10.20 Million | $-11.53 Million | $-10.79 Million | $-5.93 Million |
| Interest Expense | $384.21K | — | — | $2.57 Million | $11.72K |
| Income Before Tax | $-6.27 Million | $-9.31 Million | $-11.44 Million | $-8.28 Million | $-5.76 Million |
| Income Tax Expense | — | — | $4.00 | $-4.85 Million | $31.37K |
| Net Income | $-6.27 Million | $-9.31 Million | $-11.44 Million | $-8.28 Million | $-5.76 Million |
Genenta Science SpA ADR Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Genenta Science SpA ADR's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $31.89 Million | $14.82 Million | $22.35 Million | $33.44 Million | $40.03 Million |
| Total Current Assets | $29.98 Million | $14.47 Million | $21.26 Million | $31.72 Million | $38.76 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $22.62 Million | $8.08 Million | $15.08 Million | $0.00 | $0.00 |
| Net Receivables | $1.29 Million | $1.45 Million | $2.00 Million | $1.56 Million | $1.42 Million |
| Inventory | — | — | $2.00 | $144.69K | $76.26K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | $-34.66K | — | — |
| Total Liabilities | $10.05 Million | $2.33 Million | $1.91 Million | $2.30 Million | $1.17 Million |
| Total Current Liabilities | $2.12 Million | $2.10 Million | $1.74 Million | $2.18 Million | $1.14 Million |
| Long-term Debt | $7.60 Million | — | — | — | — |
| Net Debt | $2.08 Million | $-4.57 Million | $-3.69 Million | $-29.79 Million | $-37.24 Million |
| Total Stockholder Equity | $21.84 Million | $12.50 Million | $20.43 Million | $31.14 Million | $38.86 Million |
| Retained Earnings | $-62.59 Million | $-56.06 Million | $-47.14 Million | $-35.47 Million | $-27.02 Million |
Genenta Science SpA ADR Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Genenta Science SpA ADR generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-6.87 Million | $-6.24 Million | $-11.21 Million | $-7.42 Million | $-6.96 Million |
| Capital Expenditures | $7.62K | $4.47K | $13.79K | $27.07K | $9.01K |
| Free Cash Flow | $-6.88 Million | $-6.24 Million | $-11.22 Million | $-7.45 Million | $-6.97 Million |
| Investing Cash Flow | $-14.54 Million | $6.88 Million | $-14.89 Million | $-27.07K | $-9.01K |
| Financing Cash Flow | $22.29 Million | $270.88K | $531.00 | $0.00 | $28.74 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $1.01 Million | $847.25K | $739.88K | $722.74K | $497.10K |
| Depreciation | $28.08K | $44.52K | $42.45K | $6.14K | $4.89K |
| Change in Cash | $945.92K | $890.33K | $-26.10 Million | $-7.45 Million | $21.77 Million |
Genenta Science SpA ADR Earnings History — EPS Actual vs. Analyst Estimates
Track Genenta Science SpA ADR's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 10, 2025 | -0.20 | 0.00 | — |
| Mar 28, 2025 | -0.27 | 0.00 | — |
| Jun 30, 2021 | -0.16 | 0.00 | — |
| Mar 31, 2021 | -0.16 | 0.00 | — |
| Dec 31, 2020 | -0.13 | 0.00 | — |
| Sep 30, 2020 | -0.12 | 0.00 | — |
| Jun 30, 2020 | -0.10 | 0.00 | — |
| Mar 31, 2020 | -0.09 | 0.00 | — |